生命科学资讯

Agilent Technologies (NYSE:A) VP Sells $464,970.00 in Stock - MarketBeat

Thermo Fisher expands bioprocessing capabilities across Asia - Investing.com

Thermo Fisher (TMO) boosts Asia biopharma support with new and expanded design centers - Stock Titan

Genetic testing transformed her cancer care—and her family tree - Illumina

Hospitals challenge 340B rebate pilot program in Maine federal court

Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com

Pentagon seeks to add WuXi AppTec to military list: report

New York judge revives Bristol Myers dispute over Celgene deal

Janux T-cell engager data sink stock, but analysts still see best-in-class potential

FDA issues draft guidance to reduce primate testing for certain antibodies

Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter

CDER head Richard Pazdur set to retire shortly after appointment

FDA to remove some monkey testing from monoclonal antibody development

Richard Pazdur, FDA drug czar, to retire from agency

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts - ts2.tech

Tech emerges as a new frontier for digital therapeutics

FDA details plan to scale back animal tests for some antibody drugs

In the clinic for Dec. 2, 2025

Other news to note for Dec. 2, 2025

Regulatory actions for Dec. 2, 2025